Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.80
0.34 (2.35%)
At close: Aug 15, 2025, 1:13 PM
Denali Therapeutics Fail-to-Deliver
Total FTD Shares
7.74K
Below Average
FTD / Avg. Volume
0.48%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Denali Therapeutics Inc. has
7,741
shares failed to deliver, representing 0.48%
of the average daily volume of
1,604,672
shares. Over the past year, the monthly average FTD is
5,310
shares, with the current level 46% above
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 14.69 | 7.74K | +9456.79% |
| Jun 30, 2025 | 13.99 | 81 | -99.95% |
| May 29, 2025 | 13.54 | 163.88K | +2461.38% |
| Apr 30, 2025 | 16.65 | 6.4K | +385.06% |
| Mar 26, 2025 | 13.81 | 1.32K | +42.75% |
| Feb 25, 2025 | 19.2 | 924 | +1953.33% |
| Jan 27, 2025 | 23.19 | 45 | -95.26% |
| Dec 26, 2024 | 21.32 | 950 | +140.51% |
| Nov 21, 2024 | 24.22 | 395 | +16.52% |
| Oct 25, 2024 | 26.15 | 339 | +91.53% |
| Sep 30, 2024 | 29.13 | 177 | -91.23% |
| Aug 22, 2024 | 23.89 | 2.02K | +2826.09% |
| Jul 12, 2024 | 22.86 | 69 | -73.96% |
| Jun 25, 2024 | 22.39 | 265 | -19.21% |
| May 30, 2024 | 18.46 | 328 | -77.49% |
| Apr 29, 2024 | 15.6 | 1.46K | +291.67% |
| Mar 28, 2024 | 20.52 | 372 | +2380.00% |
| Feb 29, 2024 | 19.78 | 15 | -99.06% |
| Jan 26, 2024 | 16.87 | 1.59K | +2211.59% |
| Dec 28, 2023 | 21.95 | 69 | -32.35% |
| Nov 30, 2023 | 18.52 | 102 | -47.42% |
| Oct 30, 2023 | 18.4 | 194 | +823.81% |
| Sep 26, 2023 | 21.39 | 21 | -96.79% |
| Aug 10, 2023 | 24.24 | 655 | -40.45% |
| Jul 27, 2023 | 27.82 | 1.1K | +20.09% |
| Jun 30, 2023 | 29.51 | 916 | -9.22% |
| May 31, 2023 | 30.22 | 1.01K | +851.89% |
| Apr 28, 2023 | 24.84 | 106 | -92.21% |
| Mar 30, 2023 | 21.91 | 1.36K | -55.84% |
| Feb 28, 2023 | 27.15 | 3.08K | +9835.48% |
| Jan 27, 2023 | 31.47 | 31 | n/a |